Ligand Pharmaceuticals Incorporated (LGND) Climbed 6.47% or 16.41 To Price $270.07 On Tuesday


Ligand Pharmaceuticals Incorporated (LGND) climbed 6.47% or 16.41 to $270.07. It is about 77850 shares traded, which is 20.37% compare to the average total volume 382115. The market cap of LGND is $5.70 billion. The year to date change is 89.45%. The 52 week price range is from $126.5 to $261.33. Price of LGND have changed -1.91% during last week. It have changed 2.29% over last month, 31.10% over last 3 months, 50.64% over last 6 months and 87.70% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for LGND is 239.38. It is -11.36% below current price. The 200-day Moving Averages for LGND is 183.43. It is -32.08% below current price. The 52-week High is 261.33. The 52-week Low is 126.5. It is -53.16% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of LGND is 9.75 on 2018-08-31. Short % to float is 18.55%. There are some statistics of LGND. It is has market cap $5.70 billion. The share outstanding is 21.10 million. The average volume is 382115. The revenue is 33.38M. The gross profit is 30.99M. The percent of top 15 Institution holding is 92.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of LGND is 23.85%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of LGND is 9.60%.


Tags:

Share this post